上海物貿(600822.SH):子公司擬收購危化市場28%股權
格隆匯6月9日丨上海物貿(600822.SH)公佈,公司全資子公司上海晶通化學品有限公司(簡稱“晶通化學”)以自有資金協議收購上海晶通化輕發展有限公司(簡稱“晶通發展”)所持有的上海危險化學品交易經營管理有限公司(簡稱“危化市場”)28%股權。危化市場於評估基準日2024年12月31日的淨資產賬面值爲1129.95萬元,評估價值爲1159.74萬元,增值率2.64%。本次收購危化市場28%股權,以資產評估結果爲定價依據,確定交易價格爲3,247,262.25元。
危化市場是一家爲危險化學品經營單位提供市場管理服務的專業公司。近幾年來,危化市場影響力的逐漸擴大,場內客戶入駐率和經營貿易額穩中有升。爲進一步加強股權管理、優化治理結構,促進危化市場的持續發展與提升經營決策效率,晶通化學擬收購晶通發展持有的危化市場28%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.